首页> 外文期刊>Pharmaceutical development and technology >Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
【24h】

Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.

机译:Eudragit-S,Eudragit-L和醋酸纤维素邻苯二甲酸酯包衣的多糖片可用于结肠靶向性硫唑嘌呤的递送。

获取原文
获取原文并翻译 | 示例
           

摘要

The present work deals with the formulation and evaluation of polymer-coated polysaccharide tablets of azathioprine prepared by direct compression method using different ratios of avicel (MCC), inulin and triacetin. The tablets formulations containing 25 mg of azathioprine were prepared and evaluated for thickness, hardness, friability, weight variation, content uniformity and in vitro dissolution test. Hardness and percentage friability were in the range of 7.23-7.43 kg/cm(2) and 0.21-0.41%, respectively, and showed 99-100% uniformity in drug content. The coated tablets exploiting different polymer combinations were evaluated for drug release under different pH conditions. The formulation containing Eudragit-S, Eudragit-L and cellulose acetate phthalate (ES, EL and CAP) (1:1:1) displayed desired release pattern with only 9.75% drug release in first 5 h (lag phase) and satisfactory release in lowered pH conditions. Drug release increased with the plasticizer (triacetin) concentration. Increase in the concentration of inulin and citric acid above 5% w/w increases the drug release. The addition of inulin in the formulation with coating level 28% w/w demonstrated increased drug release in presence of rat cecal content. Thus inulin containing ES, EL and CAP (1:1:1) polymer-coated formulation system can be used for the targeted delivery of azathioprine with desired release pattern.
机译:本工作涉及通过使用不同比例的avicel(MCC),菊粉和三醋精的直接压片法制备的硫唑嘌呤聚合物包衣多糖片的配制和评价。制备含有25mg硫唑嘌呤的片剂,并对其厚度,硬度,脆性,重量变化,含量均匀性和体外溶出试验进行评估。硬度和脆碎度分别在7.23-7.43 kg / cm(2)和0.21-0.41%的范围内,并显示99-100%的药物含量均匀度。评价利用不同聚合物组合的包衣片剂在不同pH条件下的药物释放。包含Eudragit-S,Eudragit-L和邻苯二甲酸乙酸纤维素酯(ES,EL和CAP)(1:1:1:1)的制剂显示出所需的释放模式,在开始的5小时内(延迟期)仅释放9.75%的药物,并且在5h内令人满意的释放降低pH条件。药物释放随着增塑剂(三醋精)浓度的增加而增加。菊粉和柠檬酸浓度增加到5%w / w以上会增加药物释放。包衣水平为28%w / w的制剂中添加菊粉证明在大鼠盲肠含量存在下药物释放增加。因此,包含ES,EL和CAP(1:1:1)聚合物涂层的菊粉制剂体系可用于具有所需释放模式的硫唑嘌呤的靶向递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号